WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the Trump administration's crackdown on pharmaceutical advertising.

What You Need To Know

The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy

The Food and Drug Administration on Tuesday sent letters to Hims & Hers and dozens of other companies, ordering them to halt "false and misleading" statements about their medications

It's the first time regulators have gone after online prescribing services, which don't typically fall under FDA authority

The FDA says that Hims mu

See Full Page